3 reasons Coca-Cola Amatil Ltd will stay under pressure in 2016

Find out the reasons why a long-term recovery for the share price of Coca-Cola Amatil Ltd (ASX:CCL) will be difficult from here.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While it is important to keep an eye on the financial press and reports on stocks you are watching and invested in, there are also other valuable sources of data that can help paint a much fuller investment picture.

These include industry journals and academic research, and for customer-facing stocks, you can do your own "on the ground" research simply by walking into the local shops. Some recently completed studies and consumer surveys shed some light on the reasons why the earnings of Coca-Cola Amatil Ltd (ASX: CCL) will remain under pressure for some time yet.

Declining overall popularity

It might be an obvious point to make, but one reason for the decline of the share price of Coca-Cola Amatil is the declining relevance of its product. But investors should not mistake that decline as a product-specific issue related to one brand like Coca-Cola or Diet Coke.

Rather, the problem is a structural one, where the consumption of all carbonated soft drinks is falling in Australia. One estimate by global research firm Euromonitor shows that overall consumption per capita has dropped by over 15% in the last decade.

That means that Coca-Cola Amatil's products might maintain or even grow market share against rivals, but it will be competing for a shrinking overall market, which has obvious knock on effects for profitability.

Declining relevance

Not so long ago, worrying about sugar content, kilojoules and nutritional value was not something that the 18-35-year-old demographic spent too much time on.

But Generation Y and millienials have grown up bombarded by health messages and have far more access to information than ever before. And while it would be a mistake to generalise and conclude that this means that they are healthier than previous generations, it does mean that they drink less carbonated beverages.

Research confirms this, with 40% of respondents to a survey in this age bracket saying that they did not consume soft drinks, or drank less than they did a year ago, compared with just 33% two years ago.

This is especially relevant for a soft drink bottler, as this age range has always been the key target market for carbonated drinks, as can be seen in the advertising strategies that those brands employ.

Exponentially increasing choice

If you talk to a supermarket employee about which aisle has the most product turnover, it's likely they will point you in the direction of the drinks aisle. New bottled drinks debut almost every week, while poorly performing ones are "deleted" as product lines.

Energy drinks, iced teas, coconut water, flavoured water, functional wellness drinks, sparkling water, fruit juice blends and green tea-based drinks now sit alongside the "traditional" soft drinks, cordials and sports drinks that once dominated the shelves.

Once again, in an environment where the overall market attributable to ready to drink beverage sales is shrinking, increased choice further lowers the sales and profitability of established players.

Coca-Cola Amatil has attempted to counter some of these trends by entering new categories, but it is often up against popular and entrenched brands. For example, its energy drink, Mother, must compete against the international brands and marketing machines of Red Bull, V and Monster.

In addition, execution when extending the product range has been a problem, as shown in the failed launch of the original Mother, as well as more recent problems with the Barista Brothers range of milk which led to widespread recalls and damage to the new brand  just as it was trying to build a position in the market.

Coca-Cola Amatil was once a defensive portfolio staple built on Australia's love of soft drinks, but the negative trends affecting it do not appear to be temporary or cyclical, and as a result, it is difficult to make a case to buy it.

Motley Fool contributor Ry Padarath has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »